Literature DB >> 2414744

Low energies and Helifix electrodes in the successful ablation of atrioventricular conduction.

P M Holt, E G Boyd, J C Crick, E Sowton.   

Abstract

High energies delivered via standard pacing catheter electrodes produce permanent atrioventricular conduction block and generate high pressures. We investigate the use of lower energies and an active fixation electrode. Ten patients with refractory supraventricular tachycardias (six with paroxysmal atrial fibrillation, three with dual AV nodal pathways, and one with a concealed accessory atrioventricular pathway) were treated. A 6F Vitatron Helifix electrode was positioned to give the maximum His bundle deflection. Four shocks of only 50 joules each were delivered at 1-minute intervals. Long-term follow-up showed that seven patients (70%) had persistent complete heart block and two had atrial fibrillation with slower ventricular rates. Nine patients (90%) were symptom-free without antiarrhythmic therapy. Permanent pacemakers were implanted in eight patients. There were no complications resulting from the procedure. Transvenous ablation of atrioventricular conduction can be safely achieved using a Vitatron Helifix electrode and much lower energy values than have been previously employed.

Entities:  

Mesh:

Year:  1985        PMID: 2414744     DOI: 10.1111/j.1540-8159.1985.tb05875.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  3 in total

1.  Endocavitary ablation of atrioventricular conduction.

Authors:  D Cunningham; E Rowland
Journal:  Br Heart J       Date:  1990-10

2.  Transvenous ablation of atrioventricular conduction with a low energy power source.

Authors:  E Rowland; D Cunningham; A Ahsan; A Rickards
Journal:  Br Heart J       Date:  1989-11

3.  Exercise capacity and spontaneous heart rhythm after transvenous fulguration of atrioventricular conduction.

Authors:  P M Schofield; R J Bowes; N Brooks; D H Bennett
Journal:  Br Heart J       Date:  1986-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.